Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

A Study of LP-118 in Patients With Advanced Tumors

NCT05025358

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Jinan University Guangzhou, Guangdong, China
  • Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
  • First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
View Trial Details
Completed

A Study of LY3039478 in Participants With Advanced Cancer

NCT01695005

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of Miami School of Medicine Miami, Florida, United States
  • Harvard Medical School Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Columbia University Medical Center New York, United States
View Trial Details
Completed

Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL

NCT04155710

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Duke University Durham, North Carolina, United States
  • University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Completed

AZD4205 in Relapsed or Refractory Peripheral T Cell Lymphoma (JACKPOT27)

NCT06511895

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Anhui Provincial Hospital (The First Affiliated Hospital of USTC) Hefei, Anhui, China
  • The Second Hospital of Anhui Meidcine University Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
View all 19 locations
View Trial Details
Completed

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

NCT03105336

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01665794

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Wayne State University - Karmonos Cancer Center Detroit, Michigan, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04182204

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Cancer Specialists Jacksonville, Florida, United States
  • Memorial Cancer Institute at Memorial West Pembroke Pines, Florida, United States
  • IHA Hematology Oncology Consultants - Ann Arbor Ann Arbor, Michigan, United States
  • MSKCC at Basking Ridge Basking Ridge, New Jersey, United States
View all 62 locations
View Trial Details

Related conditions